79417423 - AVANTI

Information

  • Trademark
  • 79417423
  • Serial Number
    79417423
  • Filing Date
    July 18, 2024
    11 months ago
  • Transaction Date
    April 27, 2025
    2 months ago
  • Status Date
    April 08, 2025
    2 months ago
  • Status Code
    641
  • Current Location
    TMEG LAW OFFICE 104
    Employee Name
    CROWDER-SCHAEFER, ANDREW
  • Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
4
Mark Identification
AVANTI
Case File Statements
  • GS0401: Manufacturing services for others in the field of active agents, additives, or excipients for pharmaceutical preparations; manufacturing services for others in the field of lipids; cGMP manufacture of active agents, additives, or excipients, for others; cGMP manufacture of lipids, for others; manufacturing services for others in the field of active agents, additives, or excipients in pharmaceutical preparations; manufacturing services for others in the field of lipids.
  • GS0091: Apparatus and instruments for scientific research in laboratories.
  • GS0051: Lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, active agents, additives, and excipients in pharmaceutical preparations; adjuvants, polymers and excipients, including surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for pharmaceutical or medical use; immunostimulatory compounds for pharmaceutical or medical use; isotopes for medical use; transfection reagents for pharmaceutical or medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, for pharmaceutical or medical use; drug delivery auxiliary agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals.
  • GS0011: Chemical compounds for scientific or research use; lipid compounds for scientific or research use; adjuvants, polymers and excipients, including surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for scientific or research use; transfection reagents for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; standard solutions for use with analytical techniques, namely, mass spectrometry; lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles; fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, for scientific or research use; diagnostic and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; fluorophores and fluorescent probes for scientific or research use; chemical auxiliary agents as raw materials for manufacturing pharmaceutical preparations, nutrient preparations, and food supplements.
  • GS0421: Analytical laboratory services; scientific research for medical purposes; analytical laboratory services in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; research and development and consultation related thereto in the field of pharmaceuticals and chemicals; research services for others; research services for others in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; lipidomics services, namely analytical services relating to lipid metabolism in biological systems; cGMP testing services; formulation chemistry services in the field of pharmaceuticals, lipids, and chemicals; providing information relating to lipids and related compounds for scientific and medical research purposes.
Case File Event Statements
  • 2/20/2025 - 4 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/23/2025 - 4 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/23/2025 - 4 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/24/2025 - 4 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/3/2025 - 3 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/4/2025 - 3 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/9/2025 - 2 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/26/2025 - 2 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/8/2025 - 2 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR